TIMOTHY L. MOORE
CIK 1669207 · Chief Technical Officer · last filed 2026-02-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.17M
Companies
5
Total Filings
32
Lifetime Open-Market Net
-$3.33M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BLFS | Director | 44,943 | $26.10 | $1.17M | $0 | 7 | 2026-02-26 |
| CERS | Director | 205,073 | $2.56 | $525.0K | $32.2K | 14 | 2025-06-04 |
| ALLO | Chief Technical Officer | 250,713 | $1.90 | $476.4K | -$25.2K | 4 | 2025-02-05 |
| TIL | Chief Operating Officer | — | $7.92 | — | $0 | 1 | 2022-09-06 |
| Kite Pharma, Inc. (KITE) Delisted | EVP, Technical Operations | 45,661 | — | — | -$3.34M | 5 | 2017-09-27 |
Recent Filings · Page 4 of 4
32 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-12-27 | Kite Pharma, Inc. (KITE) Delisted | Grant (A) | +8,400 | $0 | EDGAR |
| 2016-03-16 | Kite Pharma, Inc. (KITE) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
Showing 31–32 of 32
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.